| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6555580 | Pathology | 2018 | 14 Pages |
Abstract
The identification of prognostic biomarkers is in evolution although a variety of transcription signatures have been shown to have utility in outcome assessment. Other molecular markers showing promise as prognostic indicators are PTEN, androgen receptors, PARP and tumour promoter (GST-pi, RASSF1, PITX2) methylation.
Related Topics
Health Sciences
Medicine and Dentistry
Forensic Medicine
Authors
Lars Egevad, Brett Delahunt, Glen Kristiansen, Hemamali Samaratunga, Murali Varma,